Clinical Trial Update: Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study [NA]

View source ↗

Summary

A double-blind, placebo-controlled clinical trial evaluating montelukast in children with chronic otitis media with effusion and conductive hearing loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conductive Hearing Loss
• Otitis Media with Effusion

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Chronic Otitis Media With Effusion, Conductive Hearing Loss | NA | Status: UNKNOWN